Definition and Overview
Sleep and the autonomic nervous system are inextricably linked. Sleep plays a pivotal role in the circadian regulation of autonomic function, and the autonomic nervous system is essential for sleep stage transitions, airway maintenance, and cardiovascular stability. When this bidirectional relationship is disrupted, a vicious cycle of mutual exacerbation between sleep disorders and autonomic dysfunction ensues.
Normal Sleep and the Autonomic Nervous System
Non-REM (NREM) Sleep
During NREM sleep (stages 1–3), parasympathetic activity becomes dominant and sympathetic activity progressively decreases [1]. In slow-wave sleep (N3), sympathetic activity decreases by approximately 50% or more compared with daytime levels, and heart rate, blood pressure, and respiratory rate reach their lowest values. This represents a period of cardiovascular "nocturnal recovery."
REM Sleep
During REM sleep, autonomic activity becomes unstable. Intermittent sympathetic bursts occur, and the amplitude of heart rate and blood pressure fluctuations increases. During phasic REM periods, where sympathetic activity surges in synchronization with rapid eye movements, the risk of arrhythmia is transiently elevated [5].
Nocturnal Blood Pressure Dipping
In healthy individuals, blood pressure decreases by 10–20% during sleep compared with daytime levels. This phenomenon is termed "dipping" and results from parasympathetic predominance and sympathetic suppression. A "non-dipping" pattern, in which nocturnal blood pressure decline is absent, suggests autonomic dysfunction and is an independent risk factor for cardiovascular disease.
Sleep Apnea and the Autonomic Nervous System
Sympathetic Hyperactivity
Obstructive sleep apnea (OSA) involves repetitive cycles of upper airway obstruction, hypoxemia, hypercapnia, and microarousals. With each apneic episode, sympathetic activation surges abruptly, causing blood pressure spikes and heart rate fluctuations [1].
In severe OSA (AHI ≥ 30), nocturnal muscle sympathetic nerve activity (MSNA) reaches approximately twice that of healthy individuals, and this sympathetic hyperactivity persists not only during sleep but also during waking hours.
Cardiovascular Outcomes
Large-scale observational studies have shown that the risk of fatal and non-fatal cardiovascular events is approximately 2.87 times higher in untreated severe OSA patients [2]. OSA is an independent risk factor for daytime hypertension, nocturnal non-dipping, atrial fibrillation, and heart failure.
Autonomic Effects of CPAP Therapy
Continuous positive airway pressure (CPAP) therapy has been reported to significantly reduce nocturnal sympathetic hyperactivity, lower blood pressure by approximately 2–3 mmHg, and restore nocturnal dipping patterns [2]. Long-term use also reduces cardiovascular event rates.
Insomnia and the Autonomic Nervous System
Hyperarousal Hypothesis
The core pathophysiology of chronic insomnia is a state of central nervous system hyperarousal [3]. Sympathetic activity is elevated throughout the entire 24-hour period, manifesting not only as nighttime sleep disturbance but also as daytime fatigue, poor concentration, and elevated resting heart rate.
HRV Changes
Nocturnal HRV analysis in insomnia patients reveals a sympathetically dominant pattern with reduced HF (parasympathetic) components and elevated LF/HF ratios [5]. This indicates insufficient parasympathetic activation even during sleep.
Therapeutic Approaches
Cognitive behavioral therapy for insomnia (CBT-I) alleviates the hyperarousal state through sleep restriction, stimulus control, and relaxation training, and has been reported to improve HRV. For pharmacotherapy, melatonin receptor agonists are more favorable for autonomic balance than benzodiazepines.
REM Sleep Behavior Disorder and the Autonomic Nervous System
REM sleep behavior disorder (RBD) is a sleep disorder in which loss of muscle atonia during REM sleep causes patients to physically enact their dreams. More than 80% of patients with idiopathic RBD convert to alpha-synucleinopathies such as Parkinson's disease or multiple system atrophy within 10–15 years [4].
Autonomic dysfunction, including orthostatic hypotension, reduced HRV, and sweating abnormalities, is frequently present in RBD patients even before disease conversion, and is interpreted as a prodromal sign of neurodegeneration.
Sleep Problems in Autonomic Dysfunction
Orthostatic Hypotension and Sleep
Orthostatic hypotension seen in conditions such as pure autonomic failure and multiple system atrophy is paradoxically often accompanied by nocturnal supine hypertension. Nocturnal hypertension induces pressure diuresis, increasing nocturia, which further exacerbates sleep fragmentation.
POTS and Sleep
Between 67% and 93% of POTS patients report sleep disturbances, with sleep onset difficulty, sleep maintenance difficulty, and excessive daytime sleepiness being common. Persistent nocturnal sympathetic hyperactivity degrades sleep quality.
Diagnostic Evaluation
- Nocturnal polysomnography (PSG): simultaneous assessment of sleep architecture, respiratory events, and heart rate variability
- Nocturnal HRV analysis: evaluation of autonomic function by sleep stage
- 24-hour ambulatory blood pressure monitoring (ABPM): confirmation of nocturnal dipping patterns
- Autonomic testing battery: tilt table test, Valsalva maneuver, QSART, etc.
Therapeutic Approaches
Treatment of sleep disorders and autonomic dysfunction requires an integrated approach addressing both conditions simultaneously. CPAP therapy for OSA, CBT-I for insomnia, and treatment of the underlying cause of autonomic dysfunction are central, with sleep hygiene education and regular exercise serving supportive roles.